[Form 4] UNIVERSAL SAFETY PRODUCTS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Universal Safety Products, Inc. (UUU) reported an insider equity award on a Form 4. A Director and Vice Chairman received 50,000 stock options (transaction code A) with an exercise price of $3.4 per share. The options were granted on August 27, 2025, subject to stockholder approval, and vested on October 20, 2025 upon that approval.

The options become exercisable once the NYSE American approves the supplemental listing application for the underlying common shares and carry an expiration date of August 26, 2035. Following the reported transaction, the filing shows 50,000 derivative securities beneficially owned, held directly.

10/22/2025 - 04:31 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AULT MILTON C III

(Last) (First) (Middle)

11411 SOUTHERN HIGHLANDS PARKWAY

SUITE 190

(Street)

LAS VEGAS NV 89141

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL SAFETY PRODUCTS, INC. [ UUU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice Chairman

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$3.4	10/20/2025		A		50,000(1)		(2)	08/26/2035	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. The stock options (the "Options") were granted on August 27, 2025, subject to stockholder approval. The Options vested on October 20, 2025, the date of stockholder approval.

2. The Options are exercisable as soon as the NYSE American approves the supplemental listing application relating to the issuance of the common stock underlying the Options.

	By: /s/ Milton C. Ault, III	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did UUU disclose in this Form 4?

A Director and Vice Chairman reported a grant of 50,000 stock options with an exercise price of $3.4 per share.

When did the UUU options vest?

They vested on October 20, 2025, the date stockholders approved the grant.

What is the exercise price and term of the options?

The exercise price is $3.4 per share, and the options expire on August 26, 2035.

When are the options exercisable?

They are exercisable once NYSE American approves the supplemental listing application for the underlying shares.

How many derivative securities does the insider hold after the transaction?

The filing shows 50,000 derivative securities beneficially owned, held directly.

What roles does the reporting person hold at UUU?

The reporting person is listed as Director and Vice Chairman.